HOUSTON, May 23, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX) today announced that company co-founder, Reese S. Terry, Jr., is the recipient of the 2012 Professional Career Achievement Award from the Institute of Electrical and Electronic Engineers (IEEE) Engineering in Medicine & Biology Society. The award recognizes his significant contributions to therapeutic implantable devices and procedures for the treatment of epilepsy and drug-resistant chronic depression.
Mr. Terry founded Cyberonics in December 1987, leading a development team that pioneered the company's first Vagus Nerve Stimulation Therapy (VNS Therapy®) system, which achieved FDA approvals for certain forms of epilepsy and depression in 1997 and 2005, respectively. "Reese's visionary works have led to significant clinical benefits for patients around the world and are consistent with the metes and bounds of this prestigious award," remarked Milton M. Morris, Ph.D., Vice President of Research and Development at Cyberonics. "We owe much of our success to Reese, who continues to be held in high regard by our employees."
During his tenure with Cyberonics, Mr. Terry served as Chief Executive Officer on two separate occasions, saw the company to public status in 1993 and was an active member of the Board of Directors until his retirement in August 2010.
About Cyberonics, Inc. and the VNS Therapy® System
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.
Greg Browne, CFO
100 Cyberonics Blvd., Houston, TX 77058
Main: (281) 228-7262/Fax: (281) 218-9332
SOURCE Cyberonics, Inc.